| 摘要 |
Compounds of formula (I) in free or pharmaceutically acceptable salt form, where R1, R2, R3, R4, R 5, R6, R7, m, n, w, X, and Y have the meanings as indicated in the specification, are useful for treating conditions mediated by the CRTh2 receptor, especially inflammatory or obstructive airways diseases.
|
